These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15606674)

  • 1. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin.
    Lazar AJ; Calonje E; Grayson W; Dei Tos AP; Mihm MC; Redston M; McKee PH
    J Cutan Pathol; 2005 Feb; 32(2):148-57. PubMed ID: 15606674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common human skin tumour is caused by activating mutations in beta-catenin.
    Chan EF; Gat U; McNiff JM; Fuchs E
    Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-catenin expression in benign and malignant pilomatrix neoplasms.
    Hassanein AM; Glanz SM
    Br J Dermatol; 2004 Mar; 150(3):511-6. PubMed ID: 15030335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
    Demirkan NC; Bir F; Erdem O; Düzcan E
    J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas.
    Palacios J; Gamallo C
    Cancer Res; 1998 Apr; 58(7):1344-7. PubMed ID: 9537226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-catenin mutations in a common skin cancer: pilomatricoma].
    Durand M; Molès JP
    Bull Cancer; 1999 Sep; 86(9):725-6. PubMed ID: 10519964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
    Chen YW; Jeng YM; Yeh SH; Chen PJ
    Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
    Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
    J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; Contreras F; Palacios J
    Br J Dermatol; 2001 Oct; 145(4):576-81. PubMed ID: 11703283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
    Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
    Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilomatrix carcinoma arising from pilomatricoma after 10-year senescent period: Immunohistochemical analysis.
    Nishioka M; Tanemura A; Yamanaka T; Tani M; Miura H; Asakura M; Tamai N; Katayama I
    J Dermatol; 2010 Aug; 37(8):735-9. PubMed ID: 20649718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.
    Ikeda S; Ishizaki Y; Shimizu Y; Fujimori M; Ojima Y; Okajima M; Sugino K; Asahara T
    Int J Oncol; 2002 Mar; 20(3):463-6. PubMed ID: 11836555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.
    Suriano G; Vrcelj N; Senz J; Ferreira P; Masoudi H; Cox K; Nabais S; Lopes C; Machado JC; Seruca R; Carneiro F; Huntsman DG
    Genes Chromosomes Cancer; 2005 Mar; 42(3):238-46. PubMed ID: 15609344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
    Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
    Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of beta-catenin and pRB pathway components in malignant ovarian germ cell tumours: INK4A promoter CpG island methylation is associated with cell proliferation.
    Kawauchi S; Liu XP; Kawasaki K; Hirakawa T; Amada S; Furuya T; Oga A; Sasaki K
    J Pathol; 2004 Nov; 204(3):268-76. PubMed ID: 15476271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours.
    Saito T; Oda Y; Tanaka K; Matsuda S; Tamiya S; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2001 Sep; 195(2):222-8. PubMed ID: 11592102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.